Holen Sie sich die Stockscreener-App
6.185
2.74%
0.165
Finanzdaten der Myriad Genetics Inc-Aktie (MYGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.84%
190.70
|
200.40 | 209.80 | 205.70 | 213.10 |
| Cost Of Revenue |
1.43%
63.70
|
62.80 | 63.00 | 61.90 | 61.30 |
| Gross Profit |
7.70%
127.00
|
137.60 | 146.80 | 143.80 | 151.80 |
| Operating Expenses |
1.43%
165.90
|
168.30 | 152.50 | 167.10 | 481.00 |
| Depreciation and Amortization |
0.00%
12.50
|
12.50 | 12.60 | 12.60 | 14.10 |
| Operating Income/Loss |
26.71%
-38.90
|
-30.70 | -5.70 | -23.30 | -329.20 |
| Nonoperating Income/Loss |
8.82%
-3.70
|
-3.40 | -3.20 | -2.90 | -1.40 |
| Income/Loss From Continuing Operations Before Tax |
24.93%
-42.60
|
-34.10 | -8.90 | -26.20 | -330.60 |
| Income Tax Expense/Benefit |
0.60
|
- | -1.00 | 1.20 | -0.10 |
| Net Income/Loss |
26.69%
-43.20
|
-34.10 | -7.90 | -27.40 | -330.50 |
| Basic Average Shares |
1.17%
94.80
|
93.70 | 0.30 | 93.10 | 92.50 |
| Diluted Average Shares |
1.17%
94.80
|
93.70 | 0.30 | 93.10 | 92.50 |
| Basic Earnings Per Share |
27.78%
-0.46
|
-0.36 | -0.07 | -0.29 | -3.57 |
| Diluted Earnings Per Share |
27.78%
-0.46
|
-0.36 | -0.07 | -0.29 | -3.57 |
0.02%
2.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):